The Federal legalization of hemp cultivation and processing in 2018 produced a rapid rise in the popularity of cannabidiol (CBD). Now other rare non-delta-9-THC cannabinoids derived from hemp have also become targets for further investigation and commercialization. Compounds such as cannabigerol (CBG) and cannabinol (CBN) may have antimicrobial, antibacterial, anti-inflammatory, anti-convulsant, and/or anti-cancer properties without the psychoactive effects of THC, creating an increased demand for their isolation from hemp. Known as “minor cannabinoids,” these compounds are found in lower concentrations than CBD. As a result, high-resolution purification methods such as Preparative HPLC are needed. In this webinar we will discuss how Teledyne ISCO’s ACCQPrep HP150 system can provide faster method development and higher resolution separations when isolating these compounds from primary hemp extracts.
Our featured guest speaker on this topic is Bryan Corey, Director of Science, Lab Society. The moderator for the event is Josh Lovell, Applications Specialist at Teledyne ISCO, responsible for helping customers solve challenging problems in analytical, flash, and preparatory chromatography applications.
• Which cannabinoids can legally be extracted from hemp cultivation in the US?
• What benefits do these compounds offer?
• How to maximize the value of your hemp extracts by commercializing the non-CBD compounds found alongside primary CBD extraction from hemp.
• Preparative HPLC as a reliable and cost-effective method for isolation of minor cannabinoids.
• How to increase throughput while reducing method development time with the automation features of the ACCQPrep HP150.
From this 45-minute presentation plus interactive Q&A session, attendees will be able to rapidly take advantage of the latest science and purification methods relating to minor cannabinoids. Also learn how to access Teledyne ISCO’s chromatography support team at any time for assistance with instrument operation and methods.

source